By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted June 3, 2021APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCE READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted June 1, 2021APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF RENUVION IN DERMAL RESURFACING PROCEDURES READ MORE